| 000 | 01109 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513143136.0 | ||
| 264 | 0 | _c19980804 | |
| 008 | 199808s 0 0 eng d | ||
| 022 | _a1091-4269 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNutt, D J | |
| 245 | 0 | 0 |
_aEfficacy of mirtazapine in clinically relevant subgroups of depressed patients. _h[electronic resource] |
| 260 |
_bDepression and anxiety _c1998 |
||
| 300 |
_a7-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xadverse effects |
| 650 | 0 | 4 |
_aAntidepressive Agents, Tricyclic _xadverse effects |
| 650 | 0 | 4 |
_aAnxiety Disorders _xclassification |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aDepressive Disorder _xclassification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMianserin _xadverse effects |
| 650 | 0 | 4 | _aMirtazapine |
| 650 | 0 | 4 |
_aNorepinephrine _xphysiology |
| 650 | 0 | 4 |
_aSerotonin _xphysiology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tDepression and anxiety _gvol. 7 Suppl 1 _gp. 7-10 |
|
| 999 |
_c9564087 _d9564087 |
||